Andrea de Bartolomeis - Publications

Affiliations: 
Neuroscience University School of Medicine of Naples Federico II Italy 
Area:
Schizophrenia, psychosis, antipsychotics, synapse, Homer

112 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 de Bartolomeis A, Barone A, Buonaguro EF, Tomasetti C, Vellucci L, Iasevoli F. The Homer1 family of proteins at the crossroad of dopamine-glutamate signaling: An emerging molecular "Lego" in the pathophysiology of psychiatric disorders. A systematic review and translational insight. Neuroscience and Biobehavioral Reviews. 136: 104596. PMID 35248676 DOI: 10.1016/j.neubiorev.2022.104596  0.712
2022 De Rosa A, Fontana A, Nuzzo T, Garofalo M, Di Maio A, Punzo D, Copetti M, Bertolino A, Errico F, Rampino A, de Bartolomeis A, Usiello A. Machine Learning algorithm unveils glutamatergic alterations in the post-mortem schizophrenia brain. Npj Schizophrenia. 8: 8. PMID 35217646 DOI: 10.1038/s41537-022-00231-1  0.32
2022 Matrone M, Kotzalidis GD, Romano A, Bozzao A, Cuomo I, Valente F, Gabaglio C, Lombardozzi G, Trovini G, Amici E, Perrini F, De Persis S, Iasevoli F, De Filippis S, de Bartolomeis A. Treatment-resistant schizophrenia: Addressing white matter integrity, intracortical glutamate levels, clinical and cognitive profiles between early- and adult-onset patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 114: 110493. PMID 34883221 DOI: 10.1016/j.pnpbp.2021.110493  0.716
2021 D'Urso G, Toscano E, Sanges V, Sauvaget A, Sheffer CE, Riccio MP, Ferrucci R, Iasevoli F, Priori A, Bravaccio C, de Bartolomeis A. Cerebellar Transcranial Direct Current Stimulation in Children with Autism Spectrum Disorder: A Pilot Study on Efficacy, Feasibility, Safety, and Unexpected Outcomes in Tic Disorder and Epilepsy. Journal of Clinical Medicine. 11. PMID 35011884 DOI: 10.3390/jcm11010143  0.682
2021 Fornaro M, Carvalho AF, De Prisco M, Mondin AM, Billeci M, Selby P, Iasevoli F, Berk M, Castle DJ, de Bartolomeis A. The prevalence, odds, predictors, and management of tobacco use disorder or nicotine dependence among people with severe mental illness: Systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews. 132: 289-303. PMID 34838527 DOI: 10.1016/j.neubiorev.2021.11.039  0.687
2021 Fornaro M, Trinchillo A, Saccà F, Iasevoli F, Nolano M, de Bartolomeis A. Pharmacotherapy to prevent the onset of depression following traumatic brain injury. Expert Opinion On Pharmacotherapy. 1-8. PMID 34530652 DOI: 10.1080/14656566.2021.1980537  0.658
2021 Iasevoli F, Razzino E, Altavilla B, Avagliano C, Barone A, Ciccarelli M, D'Ambrosio L, Matrone M, Milandri F, Notar Francesco D, Fornaro M, de Bartolomeis A. Relationships between early age at onset of psychotic symptoms and treatment resistant schizophrenia. Early Intervention in Psychiatry. PMID 33998142 DOI: 10.1111/eip.13174  0.707
2021 Barone A, Signoriello S, Latte G, Vellucci L, Giordano G, Avagliano C, Buonaguro EF, Marmo F, Tomasetti C, Iasevoli F, de Bartolomeis A. Modulation of glutamatergic functional connectivity by a prototypical antipsychotic: translational inference from a postsynaptic density Immediate-Early Gene-based network analysis. Behavioural Brain Research. 113160. PMID 33577880 DOI: 10.1016/j.bbr.2021.113160  0.8
2020 Iasevoli F, Barone A, Buonaguro EF, Vellucci L, de Bartolomeis A. Safety and tolerability of antipsychotic agents in neurodevelopmental disorders: a systematic review. Expert Opinion On Drug Safety. PMID 32892632 DOI: 10.1080/14740338.2020.1820985  0.679
2020 Iasevoli F, Buonaguro EF, Avagliano C, Barone A, Eramo A, Vellucci L, de Bartolomeis A. The Effects of Antipsychotics on the Synaptic Plasticity Gene Depend on a Combination of Their Receptor Profile, Dose, Duration of Treatment, and Brain Regions Targeted. International Journal of Molecular Sciences. 21. PMID 32756473 DOI: 10.3390/Ijms21155555  0.804
2020 Fornaro M, Fusco A, Novello S, Mosca P, Anastasia A, De Blasio A, Iasevoli F, de Bartolomeis A. Predictors of Treatment Resistance Across Different Clinical Subtypes of Depression: Comparison of Unipolar vs. Bipolar Cases. Frontiers in Psychiatry. 11: 438. PMID 32670098 DOI: 10.3389/Fpsyt.2020.00438  0.67
2020 de Bartolomeis A, Manchia M, Marmo F, Vellucci L, Iasevoli F, Barone A. Glycine Signaling in the Framework of Dopamine-Glutamate Interaction and Postsynaptic Density. Implications for Treatment-Resistant Schizophrenia. Frontiers in Psychiatry. 11: 369. PMID 32477178 DOI: 10.3389/Fpsyt.2020.00369  0.815
2020 Iasevoli F, Fornaro M, D'Urso G, Galletta D, Casella C, Paternoster M, Buccelli C, de Bartolomeis A. Psychological distress in patients with serious mental illness during the COVID-19 outbreak and one-month mass quarantine in Italy. Psychological Medicine. 1-3. PMID 32423496 DOI: 10.1017/S0033291720001841  0.636
2019 de Bartolomeis A, Avagliano C, Vellucci L, D'Ambrosio L, Manchia M, D'Urso G, Buonaguro EF, Iasevoli F. Translating preclinical findings in clinically relevant new antipsychotic targets: focus on the glutamatergic postsynaptic density. Implications for treatment resistant schizophrenia. Neuroscience and Biobehavioral Reviews. PMID 31461641 DOI: 10.1016/J.Neubiorev.2019.08.019  0.738
2019 Buonaguro EF, Morley-Fletcher S, Avagliano C, Vellucci L, Iasevoli F, Bouwalerh H, Van Camp G, Nicoletti F, Maccari S, de Bartolomeis A. Glutamatergic postsynaptic density in early life stress programming: Topographic gene expression of mGlu5 receptors and Homer proteins. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 109725. PMID 31404590 DOI: 10.1016/J.Pnpbp.2019.109725  0.7
2019 Avagliano C, Iasevoli F, Buonaguro E, Vellucci L, De Bartolomeis A. Duration of antipsychotic treatment and doses/receptor profile modulate early gene expression throughout rat brain regions European Neuropsychopharmacology. 29: S610-S611. DOI: 10.1016/J.Euroneuro.2018.11.899  0.714
2018 Iasevoli F, Avagliano C, Altavilla B, Barone A, D'Ambrosio L, Matrone M, Notar Francesco D, Razzino E, de Bartolomeis A. Disease Severity in Treatment Resistant Schizophrenia Patients Is Mainly Affected by Negative Symptoms, Which Mediate the Effects of Cognitive Dysfunctions and Neurological Soft Signs. Frontiers in Psychiatry. 9: 553. PMID 30429802 DOI: 10.3389/Fpsyt.2018.00553  0.7
2018 Iasevoli F, Avagliano C, Altavilla B, Barone A, Ciccarelli M, D'Ambrosio L, Notar Francesco D, Razzino E, Fornaro M, de Bartolomeis A. Evaluation of a few discrete clinical markers may predict categorization of actively symptomatic non-acute schizophrenia patients as treatment resistant or responders: A study by ROC curve analysis and multivariate analyses. Psychiatry Research. 269: 481-493. PMID 30195742 DOI: 10.1016/J.Psychres.2018.08.109  0.705
2018 Iasevoli F, D'Ambrosio L, Notar Francesco D, Razzino E, Buonaguro EF, Giordano S, Patterson TL, de Bartolomeis A. Clinical evaluation of functional capacity in treatment resistant schizophrenia patients: Comparison and differences with non-resistant schizophrenia patients. Schizophrenia Research. PMID 29934250 DOI: 10.1016/J.Schres.2018.06.030  0.693
2018 Fornaro M, Anastasia A, Monaco F, Novello S, Fusco A, Iasevoli F, De Berardis D, Veronese N, Solmi M, de Bartolomeis A. Clinical and psychopathological features associated with treatment-emergent mania in bipolar-II depressed outpatients exposed to antidepressants. Journal of Affective Disorders. 234: 131-138. PMID 29525354 DOI: 10.1016/J.Jad.2018.02.085  0.678
2018 de Bartolomeis A, Iasevoli F, Marmo F, Buonaguro EF, Avvisati L, Latte G, Tomasetti C. Nicotine and caffeine modulate haloperidol-induced changes in postsynaptic density transcripts expression: Translational insights in psychosis therapy and treatment resistance. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 29475793 DOI: 10.1016/J.Euroneuro.2018.01.006  0.798
2017 de Bartolomeis A, Buonaguro EF, Latte G, Rossi R, Marmo F, Iasevoli F, Tomasetti C. Immediate-Early Genes Modulation by Antipsychotics: Translational Implications for a Putative Gateway to Drug-Induced Long-Term Brain Changes. Frontiers in Behavioral Neuroscience. 11: 240. PMID 29321734 DOI: 10.3389/Fnbeh.2017.00240  0.811
2017 Bernardo P, Galletta D, Iasevoli F, D'Ambrosio L, Troisi S, Gennaro E, Zara F, Striano S, de Bartolomeis A, Coppola A. CHD2 mutations: Only epilepsy? Description of cognitive and behavioral profile in a case with a new mutation. Seizure. 51: 186-189. PMID 28910737 DOI: 10.1016/J.Seizure.2017.09.001  0.634
2017 de Bartolomeis A, Prinzivalli E, Callovini G, D'Ambrosio L, Altavilla B, Avagliano C, Iasevoli F. Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: Evidence from explanatory analysis on clinical, psychopathological, and cognitive variables. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 28887181 DOI: 10.1016/J.Pnpbp.2017.09.002  0.71
2017 Fornaro M, De Berardis D, Perna G, Solmi M, Veronese N, Orsolini L, Buonaguro EF, Iasevoli F, Köhler CA, Carvalho AF, de Bartolomeis A. Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews. Biomed Research International. 2017: 3084859. PMID 28573138 DOI: 10.1155/2017/3084859  0.664
2017 Buonaguro EF, Iasevoli F, Marmo F, Eramo A, Latte G, Avagliano C, Tomasetti C, de Bartolomeis A. Re-arrangements of gene transcripts at glutamatergic synapses after prolonged treatments with antipsychotics: A putative link with synaptic remodeling. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 28235555 DOI: 10.1016/J.Pnpbp.2017.02.012  0.812
2017 de Berardis D, Fornaro M, Orsolini L, Iasevoli F, Tomasetti C, de Bartolomeis A, Serroni N, Valchera A, Carano A, Vellante F, Marini S, Piersanti M, Perna G, Martinotti G, Di Giannantonio M. The Role of Inhaled Loxapine in the Treatment of Acute Agitation in Patients with Psychiatric Disorders: A Clinical Review. International Journal of Molecular Sciences. 18. PMID 28208695 DOI: 10.3390/Ijms18020349  0.713
2017 Iasevoli F, Fagiolini A, Formato MV, Prinzivalli E, Giordano S, Balletta R, De Luca V, de Bartolomeis A. Assessing patient-rated vs. clinician-rated adherence to the therapy in treatment resistant schizophrenia, schizophrenia responders, and non-schizophrenia patients. Psychiatry Research. 249: 159-166. PMID 28104562 DOI: 10.1016/J.Psychres.2017.01.015  0.713
2017 Tomasetti C, Iasevoli F, Buonaguro EF, De Berardis D, Fornaro M, Fiengo AL, Martinotti G, Orsolini L, Valchera A, Di Giannantonio M, de Bartolomeis A. Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular Actions. International Journal of Molecular Sciences. 18. PMID 28085108 DOI: 10.3390/Ijms18010135  0.739
2016 Orsolini L, Tomasetti C, Valchera A, Iasevoli F, Buonaguro EF, Fornaro M, Fiengo AL, Martinotti G, Vellante F, Matarazzo I, Vecchiotti R, Perna G, Di Nicola M, Carano A, de Bartolomeis A, ... ... de Bartolomeis A, et al. Current and future perspectives on the Major Depressive Disorder: Focus on the new multimodal antidepressant Vortioxetine. Cns & Neurological Disorders Drug Targets. PMID 27781949 DOI: 10.2174/1871527315666161025140111  0.691
2016 De Berardis D, Fornaro M, Orsolini L, Iasevoli F, Tomasetti C, de Bartolomeis A, Serroni N, De Lauretis I, Girinelli G, Mazza M, Valchera A, Carano A, Vellante F, Matarazzo I, Perna G, et al. Effect of agomelatine treatment on C-reactive protein levels in patients with major depressive disorder: an exploratory study in "real-world," everyday clinical practice. Cns Spectrums. 1-6. PMID 27702411 DOI: 10.1017/S1092852916000572  0.685
2016 Buonaguro EF, Tomasetti C, Chiodini P, Marmo F, Latte G, Rossi R, Avvisati L, Iasevoli F, de Bartolomeis A. Postsynaptic density protein transcripts are differentially modulated by minocycline alone or in add-on to haloperidol: Implications for treatment resistant schizophrenia. Journal of Psychopharmacology (Oxford, England). PMID 27443599 DOI: 10.1177/0269881116658987  0.824
2016 De Berardis D, Orsolini L, Iasevoli F, Prinzivalli E, de Bartolomeis A, Serroni N, Mazza M, Valchera A, Fornaro M, Vecchiotti R, Carano A, Sepede G, Vellante F, Matarazzo I, Pompili M, et al. The Novel Antipsychotic Cariprazine (RGH-188): State-of-the-Art in the Treatment of Psychiatric Disorders. Current Pharmaceutical Design. PMID 27396597 DOI: 10.1016/J.Eurpsy.2016.01.563  0.735
2016 de Bartolomeis A, Marmo F, Buonaguro EF, Latte G, Tomasetti C, Iasevoli F. Switching antipsychotics: imaging the differential effect on the topography of postsynaptic density transcripts in antipsychotic-naïve vs. antipsychotic-exposed rats. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 27177972 DOI: 10.1016/J.Pnpbp.2016.04.015  0.81
2016 Palazzo E, Luongo L, Guida F, Marabese I, Romano R, Iannotta M, Rossi F, D'Aniello A, Stella L, Marmo F, Usiello A, de Bartolomeis A, Maione S, de Novellis V. D-Aspartate drinking solution alleviates pain and cognitive impairment in neuropathic mice. Amino Acids. PMID 27115160 DOI: 10.1007/S00726-016-2205-4  0.623
2016 Orsolini L, Tomasetti C, Valchera A, Iasevoli F, Bonaguro EF, Vellante F, Fornaro M, Fiengo A, Mazza M, Vecchiotti R, Perna G, de Bartolomeis A, Martinotti G, Di Giannantonio M, De Berardis D. New advances in the treatment of generalized anxiety disorder: the multimodal antidepressant Vortioxetine. Expert Review of Neurotherapeutics. PMID 27050932 DOI: 10.1586/14737175.2016.1173545  0.686
2016 Buonaguro E, Latte G, Avvisati L, Marmo F, Iasevoli F, Tomasetti C, De Bartolomeis A. P.1.009 Effects of caffeine, nicotine and their combination with haloperidol on PSD molecules: relevance to psychiatric diseases European Neuropsychopharmacology. 26: S10-S11. DOI: 10.1016/S0924-977X(16)70012-5  0.754
2016 Buonaguro E, Iasevoli F, Latte G, Avagliano C, Vellucci L, Marmo F, Tomasetti C, De Bartolomeis A. Analysis of Homer1a expression levels as a tool to investigate antipsychotic-related perturbation of synaptic plasticity: translational implications for schizophrenia treatment strategies European Neuropsychopharmacology. 26: S233. DOI: 10.1016/S0924-977X(16)31095-1  0.806
2016 Latte G, Iasevoli F, Buonaguro E, Tomasetti C, Marmo F, Avagliano C, Vellucci L, De Bartolomeis A. Haloperidol modulates functional connectivity in the glutamate system: a postsynaptic density immediate-early gene-based network approach European Neuropsychopharmacology. 26: S224-S225. DOI: 10.1016/S0924-977X(16)31081-1  0.776
2015 de Bartolomeis A, Tomasetti C, Iasevoli F. Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor Antagonism. Cns Drugs. 29: 773-99. PMID 26346901 DOI: 10.1007/S40263-015-0278-3  0.742
2015 Iasevoli F, Giordano S, Balletta R, Latte G, Formato MV, Prinzivalli E, De Berardis D, Tomasetti C, de Bartolomeis A. Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 65: 34-48. PMID 26320028 DOI: 10.1016/J.Pnpbp.2015.08.010  0.704
2015 De Berardis D, Orsolini L, Serroni N, Girinelli G, Iasevoli F, Tomasetti C, de Bartolomeis A, Mazza M, Valchera A, Fornaro M, Perna G, Piersanti M, Di Nicola M, Cavuto M, Martinotti G, et al. A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive Disorder. Cns & Neurological Disorders Drug Targets. PMID 26295824 DOI: 10.2174/1871527314666150821103825  0.671
2015 Guida F, Luongo L, Marmo F, Romano R, Iannotta M, Napolitano F, Belardo C, Marabese I, D'Aniello A, De Gregorio D, Rossi F, Piscitelli F, Lattanzi R, de Bartolomeis A, Usiello A, et al. Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice. Molecular Brain. 8: 47. PMID 26260027 DOI: 10.1186/S13041-015-0139-5  0.587
2015 Serchov T, Clement HW, Schwarz MK, Iasevoli F, Tosh DK, Idzko M, Jacobson KA, de Bartolomeis A, Normann C, Biber K, van Calker D. Increased Signaling via Adenosine A1 Receptors, Sleep Deprivation, Imipramine, and Ketamine Inhibit Depressive-like Behavior via Induction of Homer1a. Neuron. 87: 549-62. PMID 26247862 DOI: 10.1016/J.Neuron.2015.07.010  0.69
2015 de Bartolomeis A, Errico F, Aceto G, Tomasetti C, Usiello A, Iasevoli F. D-aspartate dysregulation in Ddo(-/-) mice modulates phencyclidine-induced gene expression changes of postsynaptic density molecules in cortex and striatum. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 62: 35-43. PMID 25979765 DOI: 10.1016/J.Pnpbp.2015.05.003  0.739
2015 De Berardis D, Marini S, Serroni N, Iasevoli F, Tomasetti C, de Bartolomeis A, Mazza M, Tempesta D, Valchera A, Fornaro M, Pompili M, Sepede G, Vellante F, Orsolini L, Martinotti G, et al. Targeting the Noradrenergic System in Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis of Prazosin Trials. Current Drug Targets. 16: 1094-106. PMID 25944011 DOI: 10.2174/1389450116666150506114108  0.674
2015 Fornaro M, De Berardis D, Mazza M, Pino M, Favaretto E, Bedani F, Wieser C, Indelicato L, Paternò VF, Lo Monaco F, Dugo F, Ventriglio A, Mungo S, Selle V, Valchera A, ... ... De Bartolomeis A, et al. Factor structure and reliability of the Italian adaptation of the Hypomania Check List-32, second revision (HCL-32-R2). Journal of Affective Disorders. 178: 112-20. PMID 25805403 DOI: 10.1016/J.Jad.2015.03.001  0.657
2015 Errico F, D'Argenio V, Sforazzini F, Iasevoli F, Squillace M, Guerri G, Napolitano F, Angrisano T, Di Maio A, Keller S, Vitucci D, Galbusera A, Chiariotti L, Bertolino A, de Bartolomeis A, et al. A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice. Translational Psychiatry. 5: e512. PMID 25689573 DOI: 10.1016/S0924-9338(15)31301-8  0.731
2015 de Bartolomeis A, Iasevoli F, Marmo F, Buonaguro EF, Eramo A, Rossi R, Avvisati L, Latte G, Tomasetti C. Progressive recruitment of cortical and striatal regions by inducible postsynaptic density transcripts after increasing doses of antipsychotics with different receptor profiles: insights for psychosis treatment. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 566-82. PMID 25649681 DOI: 10.1016/J.Euroneuro.2015.01.003  0.817
2015 De Berardis D, Fornaro M, Serroni N, Campanella D, Rapini G, Olivieri L, Srinivasan V, Iasevoli F, Tomasetti C, De Bartolomeis A, Valchera A, Perna G, Mazza M, Di Nicola M, Martinotti G, et al. Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression. International Journal of Molecular Sciences. 16: 1111-30. PMID 25569089 DOI: 10.3390/Ijms16011111  0.696
2015 Guida F, Luongo L, Marmo F, Romano R, Iannotta M, Napolitano F, Belardo C, Marabese I, D'Aniello A, De Gregorio D, Rossi F, Piscitelli F, Lattanzi R, De Bartolomeis A, Usiello A, et al. Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice Molecular Brain. 8. DOI: 10.1186/s13041-015-0139-5  0.582
2015 de Bartolomeis A, Tomasetti C, Iasevoli F. Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor Antagonism Cns Drugs. DOI: 10.1007/s40263-015-0278-3  0.706
2014 de Bartolomeis A, Iasevoli F, Tomasetti C, Buonaguro EF. MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine-Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective. Molecular Neurobiology. PMID 25394379 DOI: 10.1007/S12035-014-8962-8  0.719
2014 Quarantelli M, Palladino O, Prinster A, Schiavone V, Carotenuto B, Brunetti A, Marsili A, Casiello M, Muscettola G, Salvatore M, de Bartolomeis A. Patients with poor response to antipsychotics have a more severe pattern of frontal atrophy: a voxel-based morphometry study of treatment resistance in schizophrenia. Biomed Research International. 2014: 325052. PMID 25157354 DOI: 10.1155/2014/325052  0.664
2014 Iasevoli F, Buonaguro EF, Sarappa C, Marmo F, Latte G, Rossi R, Eramo A, Tomasetti C, de Bartolomeis A. Regulation of postsynaptic plasticity genes' expression and topography by sustained dopamine perturbation and modulation by acute memantine: relevance to schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 54: 299-314. PMID 25025505 DOI: 10.1016/J.Pnpbp.2014.07.003  0.828
2014 Iasevoli F, Tomasetti C, Buonaguro EF, de Bartolomeis A. The glutamatergic aspects of schizophrenia molecular pathophysiology: role of the postsynaptic density, and implications for treatment. Current Neuropharmacology. 12: 219-38. PMID 24851087 DOI: 10.2174/1570159X12666140324183406  0.742
2014 Iasevoli F, Buonaguro EF, Marconi M, Di Giovambattista E, Rapagnani MP, De Berardis D, Martinotti G, Mazza M, Balletta R, Serroni N, Di Giannantonio M, de Bartolomeis A, Valchera A. Efficacy and clinical determinants of antipsychotic polypharmacy in psychotic patients experiencing an acute relapse and admitted to hospital stay: results from a cross-sectional and a subsequent longitudinal pilot study. Isrn Pharmacology. 2014: 762127. PMID 24592333 DOI: 10.1155/2014/762127  0.683
2014 de Bartolomeis A, Buonaguro EF, Iasevoli F, Tomasetti C. The emerging role of dopamine-glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: Implications for treatment. Journal of Psychopharmacology (Oxford, England). 28: 505-526. PMID 24554693 DOI: 10.1177/0269881114523864  0.73
2014 de Bartolomeis A, Latte G, Tomasetti C, Iasevoli F. Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for novel therapeutic approaches. Molecular Neurobiology. 49: 484-511. PMID 23999870 DOI: 10.1007/S12035-013-8534-3  0.742
2014 Marmo F, Buonaguro E, Latte G, Iasevoli F, De Bartolomeis A. P.3.c.008 Immediate early and constitutive genes expression in antipsychotic switching paradigm: from clinical practice to animal model European Neuropsychopharmacology. 24: S519. DOI: 10.1016/S0924-977X(14)70831-4  0.774
2014 Iasevoli F, Tomasetti C, Buonaguro EF, Latte G, Rossi R, Avvisati L, Avagliano C, Fico G, Mazzola G, Marmo F, de Bartolomeis A. Poster #T100 MINOCYCLINE ADD-ON TO HALOPERIDOL BLUNTS HALOPERIDOL-MEDIATED EXPRESSION OF EARLY GENES IMPLICATED IN GLUTAMATERGIC NEUROTRANSMISSION IN BOTH VEHICLE AND KETAMINE-TREATED RATS Schizophrenia Research. 153: S325. DOI: 10.1016/S0920-9964(14)70917-X  0.782
2014 Iasevoli F, Giordano S, Balletta R, Buonaguro EF, Tomasetti C, Rossi R, Gilardi V, Cucciniello C, Elce C, Acampora R, de Bartolomeis A. Poster #M252 PATIENTS' OPINIONS ON KEY ISSUES OF PSYCHOSOCIAL FUNCTIONING AMONG NON-PSYCHOTICS PSYCHOTIC RESPONDERS AND NON-RESPONDERS: CORRELATION WITH CLINICAL VARIABLES AND SYMPTOM DOMAINS RELEVANT TO REMISSION FROM PSYCHOSIS Schizophrenia Research. 153: S281. DOI: 10.1016/S0920-9964(14)70802-3  0.67
2014 Iasevoli F, Giordano S, Balletta R, Avvisati L, Latte G, Gilardi V, Buonaguro EF, Formato M, Prinzivalli E, Rossi R, de Bartolomeis A. Poster #S257 TOUCHING BY HAND HOW PSYCHOTIC FEATURES TRANSLATE INTO WORSE LIFE CONDITIONS: THE RELATION OF KEY PSYCHOSOCIAL ISSUES WITH CLINICAL VARIABLES IN NON-PSYCHOTIC, PSYCHOTIC RESPONDER, AND PSYCHOTIC NON-RESPONDER PATIENTS Schizophrenia Research. 153: S183. DOI: 10.1016/S0920-9964(14)70536-5  0.665
2013 Iasevoli F, Balletta R, Gilardi V, Giordano S, de Bartolomeis A. Tobacco smoking in treatment-resistant schizophrenia patients is associated with impaired cognitive functioning, more severe negative symptoms, and poorer social adjustment. Neuropsychiatric Disease and Treatment. 9: 1113-20. PMID 23950651 DOI: 10.2147/NDT.S47571  0.685
2013 de Bartolomeis A, Balletta R, Giordano S, Buonaguro EF, Latte G, Iasevoli F. Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses. Psychiatry Research. 210: 387-95. PMID 23910239 DOI: 10.1016/J.Psychres.2013.06.042  0.716
2013 Iasevoli F, Aloj L, Latte G, Avvisati L, Marmo F, Tomasetti C, Buonaguro EF, Simeoli C, Pivonello R, Colao A, de Bartolomeis A. The glucocorticoid analog dexamethasone alters the expression and the distribution of dopamine receptors and enkephalin within cortico-subcortical regions. Current Molecular Pharmacology. 6: 149-55. PMID 23862670 DOI: 10.2174/187446720603140415215941  0.79
2013 Iasevoli F, Valchera A, Di Giovambattista E, Marconi M, Rapagnani MP, De Berardis D, Martinotti G, Fornaro M, Mazza M, Tomasetti C, Buonaguro EF, Di Giannantonio M, Perugi G, de Bartolomeis A. Affective temperaments are associated with specific clusters of symptoms and psychopathology: a cross-sectional study on bipolar disorder inpatients in acute manic, mixed, or depressive relapse. Journal of Affective Disorders. 151: 540-50. PMID 23856282 DOI: 10.1016/J.Jad.2013.06.041  0.676
2013 de Bartolomeis A, Avvisati L, Iasevoli F, Tomasetti C. Intracellular pathways of antipsychotic combined therapies: implication for psychiatric disorders treatment. European Journal of Pharmacology. 718: 502-23. PMID 23834777 DOI: 10.1016/J.Ejphar.2013.06.034  0.717
2013 de Bartolomeis A, Sarappa C, Buonaguro EF, Marmo F, Eramo A, Tomasetti C, Iasevoli F. Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 46: 1-12. PMID 23800465 DOI: 10.1016/J.Pnpbp.2013.06.010  0.826
2013 De Berardis D, Marini S, Iasevoli F, Tomasetti C, de Bartolomeis A, Mazza M, Valchera A, Fornaro M, Cavuto M, Srinivasan V, Sepede G, Martinotti G, Di Giannantonio M. The role of intranasal oxytocin in the treatment of patients with schizophrenia: a systematic review. Cns & Neurological Disorders Drug Targets. 12: 252-64. PMID 23469841 DOI: 10.2174/1871527311312020012  0.713
2013 de Bartolomeis A, Marmo F, Buonaguro EF, Rossi R, Tomasetti C, Iasevoli F. Imaging brain gene expression profiles by antipsychotics: region-specific action of amisulpride on postsynaptic density transcripts compared to haloperidol. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1516-29. PMID 23357084 DOI: 10.1016/J.Euroneuro.2012.11.014  0.816
2013 de Bartolomeis A, Buonaguro EF, Iasevoli F. Serotonin-glutamate and serotonin-dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins. Psychopharmacology. 225: 1-19. PMID 23179966 DOI: 10.1007/S00213-012-2921-8  0.726
2013 Iasevoli F, Tomasetti C, de Bartolomeis A. Scaffolding proteins of the post-synaptic density contribute to synaptic plasticity by regulating receptor localization and distribution: relevance for neuropsychiatric diseases. Neurochemical Research. 38: 1-22. PMID 22991141 DOI: 10.1007/S11064-012-0886-Y  0.688
2013 Iasevoli F, Avvisati L, Latte G, Buonaguro EF, Tomasetti C, Aloj L, De Bartolomeis A. Differential adaptive changes in dopaminergic system by acute vs. subchronic ketamine: Relevance for psychosis pathophysiology and treatment Current Signal Transduction Therapy. 8: 119-128. DOI: 10.2174/15743624113086660004  0.689
2013 Buonaguro E, Marmo F, Sarappa C, Eramo A, Tomasetti C, Iasevoli F, De Bartolomeis A. P.1.g.054 Gene-expression imaging by N-methyl-D-aspartate receptor antagonists: implications for dopamine–glutamate interplay in psychosis European Neuropsychopharmacology. 23: S220-S221. DOI: 10.1016/S0924-977X(13)70341-9  0.787
2012 Iasevoli F, Latte G, Avvisati L, Sarappa C, Aloj L, de Bartolomeis A. The expression of genes involved in glucose metabolism is affected by N-methyl-D-aspartate receptor antagonism: a putative link between metabolism and an animal model of psychosis. Journal of Neuroscience Research. 90: 1756-67. PMID 22605548 DOI: 10.1002/Jnr.23071  0.701
2012 de Bartolomeis A, Sarappa C, Magara S, Iasevoli F. Targeting glutamate system for novel antipsychotic approaches: relevance for residual psychotic symptoms and treatment resistant schizophrenia. European Journal of Pharmacology. 682: 1-11. PMID 22387855 DOI: 10.1016/J.Ejphar.2012.02.033  0.741
2012 Panariello F, Perruolo G, Cassese A, Giacco F, Botta G, Barbagallo AP, Muscettola G, Beguinot F, Formisano P, de Bartolomeis A. Clozapine impairs insulin action by up-regulating Akt phosphorylation and Ped/Pea-15 protein abundance. Journal of Cellular Physiology. 227: 1485-92. PMID 21618539 DOI: 10.1002/jcp.22864  0.58
2012 Iasevoli F, Balletta R, Giordano S, Buonaguro E, Latte G, de Bartolomeis A. P.3.c.043 Resistance to antipsychotics is associated with higher cognitive impairment compared to non-resistant schizophrenia European Neuropsychopharmacology. 22: S341-S342. DOI: 10.1016/S0924-977X(12)70527-8  0.693
2011 Iasevoli F, Cicale M, Abbott LC, de Bartolomeis A. Striatal expression of Homer1a is affected by genotype but not dystonic phenotype of tottering mice: a model of spontaneously occurring motor disturbances. Neuroscience Letters. 503: 176-80. PMID 21884752 DOI: 10.1016/J.Neulet.2011.08.025  0.675
2011 Tomasetti C, Dell'Aversano C, Iasevoli F, Marmo F, de Bartolomeis A. The acute and chronic effects of combined antipsychotic-mood stabilizing treatment on the expression of cortical and striatal postsynaptic density genes. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 35: 184-97. PMID 21055435 DOI: 10.1016/J.Pnpbp.2010.10.025  0.814
2011 Iasevoli F, Ambesi-Impiombato A, Fiore G, Panariello F, Muscettola G, de Bartolomeis A. Pattern of acute induction of Homer1a gene is preserved after chronic treatment with first- and second-generation antipsychotics: effect of short-term drug discontinuation and comparison with Homer1a-interacting genes. Journal of Psychopharmacology (Oxford, England). 25: 875-87. PMID 20147574 DOI: 10.1177/0269881109358199  0.808
2011 Calandro S, Avvisati L, Latte G, Patrì A, Rossi R, Buonaguro E, Sarappa C, Iasevoli F, Aloj L, de Bartolomeis A. P.1.032 Where and when ketamine alters the dopamine system: translational implications for drug addiction and psychoses European Neuropsychopharmacology. 21: S26-S27. DOI: 10.1016/S0924-977X(11)70031-1  0.686
2011 Marmo F, Latte G, Avvisati L, Patrì A, Rossi R, Buonaguro E, Tomasetti C, Iasevoli F, Aloj L, de Bartolomeis A. P.1.031 Expression of glucose metabolism genes in a psychosis model: a molecular link between NMDA receptor hypofunction and metabolism disorders? European Neuropsychopharmacology. 21: S25-S26. DOI: 10.1016/S0924-977X(11)70030-X  0.763
2010 Iasevoli F, Tomasetti C, Marmo F, Bravi D, Arnt J, de Bartolomeis A. Divergent acute and chronic modulation of glutamatergic postsynaptic density genes expression by the antipsychotics haloperidol and sertindole. Psychopharmacology. 212: 329-44. PMID 20652539 DOI: 10.1007/S00213-010-1954-0  0.817
2010 Iasevoli F, Fiore G, Cicale M, Muscettola G, de Bartolomeis A. Haloperidol induces higher Homer1a expression than risperidone, olanzapine and sulpiride in striatal sub-regions. Psychiatry Research. 177: 255-60. PMID 20304506 DOI: 10.1016/J.Psychres.2010.02.009  0.825
2009 De Luca V, Annesi G, De Marco EV, de Bartolomeis A, Nicoletti G, Pugliese P, Muscettola G, Barone P, Quattrone A. HOMER1 promoter analysis in Parkinson's disease: association study with psychotic symptoms. Neuropsychobiology. 59: 239-45. PMID 19648775 DOI: 10.1159/000230689  0.612
2009 Iasevoli F, Tomasetti C, Ambesi-Impiombato A, Muscettola G, de Bartolomeis A. Dopamine receptor subtypes contribution to Homer1a induction: insights into antipsychotic molecular action. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 33: 813-21. PMID 19243698 DOI: 10.1016/J.Pnpbp.2009.02.009  0.816
2009 Dell'aversano C, Tomasetti C, Iasevoli F, de Bartolomeis A. Antipsychotic and antidepressant co-treatment: effects on transcripts of inducible postsynaptic density genes possibly implicated in behavioural disorders. Brain Research Bulletin. 79: 123-9. PMID 19189858 DOI: 10.1016/J.Brainresbull.2009.01.006  0.759
2008 Souza RP, De Luca V, Muscettola G, Rosa DV, de Bartolomeis A, Romano Silva M, Kennedy JL. Association of antipsychotic induced weight gain and body mass index with GNB3 gene: a meta-analysis. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 32: 1848-53. PMID 18793692 DOI: 10.1016/j.pnpbp.2008.08.014  0.617
2008 Iasevoli F, Ambesi-Impiombato A, Fiore G, Panariello F, Muscettola G, de Bartolomeis A. P.1.17 Topographical and temporal distribution of Homer1a expression is correlated to antipsychotics dopaminergic profile European Neuropsychopharmacology. 18: s15-s16. DOI: 10.1016/S0924-977X(08)70018-X  0.685
2007 Tomasetti C, Dell'Aversano C, Iasevoli F, de Bartolomeis A. Homer splice variants modulation within cortico-subcortical regions by dopamine D2 antagonists, a partial agonist, and an indirect agonist: implication for glutamatergic postsynaptic density in antipsychotics action. Neuroscience. 150: 144-58. PMID 17916411 DOI: 10.1016/J.Neuroscience.2007.08.022  0.724
2007 Ambesi-Impiombato A, Panariello F, Dell'aversano C, Tomasetti C, Muscettola G, de Bartolomeis A. Differential expression of Homer 1 gene by acute and chronic administration of antipsychotics and dopamine transporter inhibitors in the rat forebrain. Synapse (New York, N.Y.). 61: 429-39. PMID 17372981 DOI: 10.1002/syn.20385  0.683
2007 Iasevoli F, Polese D, Ambesi-Impiombato A, Muscettola G, de Bartolomeis A. Ketamine-related expression of glutamatergic postsynaptic density genes: possible implications in psychosis. Neuroscience Letters. 416: 1-5. PMID 17317002 DOI: 10.1016/J.Neulet.2007.01.041  0.824
2005 de Bartolomeis A, Fiore G, Iasevoli F. Dopamine-glutamate interaction and antipsychotics mechanism of action: implication for new pharmacological strategies in psychosis. Current Pharmaceutical Design. 11: 3561-94. PMID 16248808 DOI: 10.2174/138161205774414538  0.742
2003 de Bartolomeis A, Iasevoli F. The Homer family and the signal transduction system at glutamatergic postsynaptic density: potential role in behavior and pharmacotherapy. Psychopharmacology Bulletin. 37: 51-83. PMID 14608240  0.702
2003 Ambesi-Impiombato A, D'Urso G, Muscettola G, de Bartolomeis A. Method for quantitative in situ hybridization histochemistry and image analysis applied for Homer1a gene expression in rat brain. Brain Research. Brain Research Protocols. 11: 189-96. PMID 12842224 DOI: 10.1016/S1385-299X(03)00056-4  0.619
2003 Fiore G, Cicale M, Magara S, Mondola R, Muscettola G, de Bartolomeis A. Antipsychotics with different D2 dopamine receptor potency affect differently the postsynaptic density protein homer at glutamatergic metabotropic synapse Schizophrenia Research. 60: 106. DOI: 10.1016/S0920-9964(03)80841-1  0.671
2003 Eramo A, Fiore G, Gentile S, Pellegrino F, Muscettola G, de Bartolomeis A. The forgotten therapy: Depot neuroleptics in the era of atypical antipsychotics, a community based study Schizophrenia Research. 60: 38. DOI: 10.1016/S0920-9964(03)80111-1  0.728
2002 Polese D, de Serpis AA, Ambesi-Impiombato A, Muscettola G, de Bartolomeis A. Homer 1a gene expression modulation by antipsychotic drugs: involvement of the glutamate metabotropic system and effects of D-cycloserine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 27: 906-13. PMID 12464447 DOI: 10.1016/S0893-133X(02)00371-8  0.708
2002 Cicale M, Ambesi-Impiombato A, Cimini V, Fiore G, Muscettola G, Abbott LC, de Bartolomeis A. Decreased gene expression of calretinin and ryanodine receptor type 1 in tottering mice. Brain Research Bulletin. 59: 53-8. PMID 12372549 DOI: 10.1016/S0361-9230(02)00841-9  0.624
2002 de Bartolomeis A, Aloj L, Ambesi-Impiombato A, Bravi D, Caracò C, Muscettola G, Barone P. Acute administration of antipsychotics modulates Homer striatal gene expression differentially. Brain Research. Molecular Brain Research. 98: 124-9. PMID 11834303 DOI: 10.1016/S0169-328X(01)00327-8  0.702
2001 De Bartolomeis A, Polese D, Amato de Serpis A, Iasevoli F, Ambesi-Impiombato A, Galietta A, Muscettola G. NMDA receptor hypofunction: Cortical and subcortical CaMKII mRNA gene expression European Neuropsychopharmacology. 11: S290. DOI: 10.1016/S0924-977X(01)80381-3  0.788
2000 de Bartolomeis A, Aloj L, Ambesi A, Bravi D, Caraco C, Cicale M, Muscettola G, Barone P. Postsynaptic density protein gene expression after typical or atypical antipsychotics administration Schizophrenia Research. 41: 246. DOI: 10.1016/S0920-9964(00)90921-6  0.665
1997 De Bartolomeis A, Koprivica V, Pickar D, Crawley JN, Abbott LC. Opioidergic and dopaminergic gene expression in the caudate-putamen and accumbens of the mutant mouse, tottering (tg/tg). Brain Research. Molecular Brain Research. 46: 321-4. PMID 9191109 DOI: 10.1016/S0169-328X(97)00027-2  0.587
1997 Carson RE, Breier A, de Bartolomeis A, Saunders RC, Su TP, Schmall B, Der MG, Pickar D, Eckelman WC. Quantification of amphetamine-induced changes in [11C]raclopride binding with continuous infusion. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 17: 437-47. PMID 9143226 DOI: 10.1097/00004647-199704000-00009  0.422
1997 Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, de Bartolomeis A, Weinberger DR, Weisenfeld N, Malhotra AK, Eckelman WC, Pickar D. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proceedings of the National Academy of Sciences of the United States of America. 94: 2569-74. PMID 9122236 DOI: 10.1073/Pnas.94.6.2569  0.536
1995 Holmes PV, de Bartolomeis A, Koprivica V, Crawley JN. Lack of effect of chronic morphine treatment and naloxone-precipitated withdrawal on tyrosine hydroxylase, galanin, and neuropeptide Y mRNA levels in the rat locus coeruleus. Synapse (New York, N.Y.). 19: 197-205. PMID 7540319 DOI: 10.1002/syn.890190307  0.609
1995 Breier A, Carson R, Eckelman W, de Bartolomeis A, Saunders R, Weinberger D, Su T, Pickar D. In vivo estimates of synaptic dopamine concentrations with 11C-raclopride/pet: A direct test of the dopamine hypothesis Schizophrenia Research. 15: 76-77. DOI: 10.1016/0920-9964(95)95240-A  0.461
1994 de Bartolomeis A, Austin MC, Goodwin GA, Spear LP, Pickar D, Crawley JN. Dopaminergic and peptidergic mRNA levels in juvenile rat brain after prenatal cocaine treatment. Brain Research. Molecular Brain Research. 21: 321-32. PMID 7909578 DOI: 10.1016/0169-328X(94)90263-1  0.588
1990 Muscettola G, Barbato G, de Bartolomeis A, Monteleone P, Pickar D. Plasma HVA, tardive dyskinesia and psychotic symptoms in long-term drug-free inpatients with schizophrenia. Psychiatry Research. 33: 259-67. PMID 2243901 DOI: 10.1016/0165-1781(90)90042-4  0.719
1989 Muscettola G, de Bartolomeis A, Barbato G, Nerozzi D. Plasma HVA in schizophreniform disorder and chronic schizophrenia Schizophrenia Research. 2: 169. DOI: 10.1016/0920-9964(89)90205-3  0.647
Show low-probability matches.